Edwards Lifesciences: Leadership and Innovation in Structural Heart
Spun off from Baxter 25 years ago, Edwards Lifesciences charted its own course by prioritizing surgical valves over the rapidly growing sector of interventional cardiology, a counterintuitive move that laid the foundation for lasting success. CEO Bernard Zovighian highlights Edwards’ continuing formula for success, built around innovation, trusted partnerships, and a patient-first culture.
Read Article